Correlation Between AstraZeneca PLC and Cell Impact

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both AstraZeneca PLC and Cell Impact at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining AstraZeneca PLC and Cell Impact into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between AstraZeneca PLC and Cell Impact AB, you can compare the effects of market volatilities on AstraZeneca PLC and Cell Impact and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in AstraZeneca PLC with a short position of Cell Impact. Check out your portfolio center. Please also check ongoing floating volatility patterns of AstraZeneca PLC and Cell Impact.

Diversification Opportunities for AstraZeneca PLC and Cell Impact

0.79
  Correlation Coefficient

Poor diversification

The 3 months correlation between AstraZeneca and Cell is 0.79. Overlapping area represents the amount of risk that can be diversified away by holding AstraZeneca PLC and Cell Impact AB in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Cell Impact AB and AstraZeneca PLC is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on AstraZeneca PLC are associated (or correlated) with Cell Impact. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Cell Impact AB has no effect on the direction of AstraZeneca PLC i.e., AstraZeneca PLC and Cell Impact go up and down completely randomly.

Pair Corralation between AstraZeneca PLC and Cell Impact

Assuming the 90 days trading horizon AstraZeneca PLC is expected to generate 0.17 times more return on investment than Cell Impact. However, AstraZeneca PLC is 6.0 times less risky than Cell Impact. It trades about 0.04 of its potential returns per unit of risk. Cell Impact AB is currently generating about 0.0 per unit of risk. If you would invest  131,135  in AstraZeneca PLC on August 26, 2024 and sell it today you would earn a total of  15,065  from holding AstraZeneca PLC or generate 11.49% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthSignificant
Accuracy100.0%
ValuesDaily Returns

AstraZeneca PLC  vs.  Cell Impact AB

 Performance 
       Timeline  
AstraZeneca PLC 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days AstraZeneca PLC has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of weak performance in the last few months, the Stock's basic indicators remain comparatively stable which may send shares a bit higher in December 2024. The newest uproar may also be a sign of mid-term up-swing for the firm private investors.
Cell Impact AB 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Cell Impact AB has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of uncertain performance in the last few months, the Stock's basic indicators remain comparatively stable which may send shares a bit higher in December 2024. The newest uproar may also be a sign of mid-term up-swing for the firm private investors.

AstraZeneca PLC and Cell Impact Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with AstraZeneca PLC and Cell Impact

The main advantage of trading using opposite AstraZeneca PLC and Cell Impact positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if AstraZeneca PLC position performs unexpectedly, Cell Impact can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Cell Impact will offset losses from the drop in Cell Impact's long position.
The idea behind AstraZeneca PLC and Cell Impact AB pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Insider Screener module to find insiders across different sectors to evaluate their impact on performance.

Other Complementary Tools

Stock Tickers
Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites
Price Exposure Probability
Analyze equity upside and downside potential for a given time horizon across multiple markets
Aroon Oscillator
Analyze current equity momentum using Aroon Oscillator and other momentum ratios
Options Analysis
Analyze and evaluate options and option chains as a potential hedge for your portfolios
Companies Directory
Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals